UBS AM’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12M Buy
39,809
+13,446
+51% +$4.07M ﹤0.01% 1269
2025
Q1
$8.73M Sell
26,363
-1,175
-4% -$389K ﹤0.01% 1289
2024
Q4
$8.5M Buy
27,538
+5,182
+23% +$1.6M ﹤0.01% 1327
2024
Q3
$4.74M Sell
22,356
-2,253
-9% -$478K ﹤0.01% 1599
2024
Q2
$6.89M Buy
24,609
+10,374
+73% +$2.91M ﹤0.01% 1315
2024
Q1
$3.8M Hold
14,235
﹤0.01% 1381
2023
Q4
$3.29M Sell
14,235
-1,591
-10% -$368K ﹤0.01% 1448
2023
Q3
$2.31M Buy
15,826
+354
+2% +$51.7K ﹤0.01% 1549
2023
Q2
$3.75M Hold
15,472
﹤0.01% 1361
2023
Q1
$3.75M Buy
+15,472
New +$3.75M ﹤0.01% 1361
2022
Q4
Sell
-16,634
Closed -$1.08M 2667
2022
Q3
$1.08M Hold
16,634
﹤0.01% 1919
2022
Q2
$1.19M Buy
16,634
+4,204
+34% +$301K ﹤0.01% 1865
2022
Q1
$1.22M Hold
12,430
﹤0.01% 2027
2021
Q4
$1.05M Hold
12,430
﹤0.01% 2190
2021
Q3
$992K Hold
12,430
﹤0.01% 2168
2021
Q2
$1.21M Buy
12,430
+607
+5% +$59.1K ﹤0.01% 2113
2021
Q1
$1.38M Buy
11,823
+2,122
+22% +$248K ﹤0.01% 1925
2020
Q4
$1.08M Buy
9,701
+317
+3% +$35.2K ﹤0.01% 1949
2020
Q3
$1.11M Buy
9,384
+769
+9% +$91.3K ﹤0.01% 1795
2020
Q2
$976K Buy
8,615
+5,023
+140% +$569K ﹤0.01% 1827
2020
Q1
$240K Sell
3,592
-3,444
-49% -$230K ﹤0.01% 2219
2019
Q4
$641K Buy
7,036
+3,344
+91% +$305K ﹤0.01% 2132
2019
Q3
$318K Buy
3,692
+616
+20% +$53.1K ﹤0.01% 2436
2019
Q2
$322K Hold
3,076
﹤0.01% 2386
2019
Q1
$385K Buy
3,076
+276
+10% +$34.6K ﹤0.01% 2212
2018
Q4
$316K Sell
2,800
-1,173
-30% -$132K ﹤0.01% 2195
2018
Q3
$851K Sell
3,973
-673
-14% -$144K ﹤0.01% 1873
2018
Q2
$1.3M Buy
+4,646
New +$1.3M ﹤0.01% 1707
2016
Q2
Sell
-889
Closed -$7K 2630
2016
Q1
$7K Sell
889
-36
-4% -$283 ﹤0.01% 2627
2015
Q4
$11K Hold
925
﹤0.01% 2696
2015
Q3
$56K Hold
925
﹤0.01% 2650
2015
Q2
$72K Buy
925
+94
+11% +$7.32K ﹤0.01% 2684
2015
Q1
$56K Buy
831
+117
+16% +$7.88K ﹤0.01% 2610
2014
Q4
$66K Hold
714
﹤0.01% 2598
2014
Q3
$75K Hold
714
﹤0.01% 2536
2014
Q2
$102K Hold
714
﹤0.01% 2528
2014
Q1
$108K Hold
714
﹤0.01% 2538
2013
Q4
$131K Buy
714
+98
+16% +$18K ﹤0.01% 2474
2013
Q3
$136K Hold
616
﹤0.01% 2417
2013
Q2
$108K Buy
+616
New +$108K ﹤0.01% 2397